OS Fund logo

OS Fund

North America, Illinois, United States, Chicago

Description

Investing in entrepreneurs, inventors and scientists who aim to benefit humanity by rewriting the operating systems of life.

Investor Profile

OS Fund has made 45 investments, with 0 in the past 12 months and 13% as lead.

Stage Focus

  • Seed (33%)
  • Series A (29%)
  • Series B (24%)
  • Series Unknown (4%)
  • Series D (4%)
  • Series C (2%)
  • Pre Seed (2%)

Country Focus

  • United States (91%)
  • Canada (9%)

Industry Focus

  • Biotechnology
  • Health Care
  • Health Diagnostics
  • Medical
  • Genetics
  • Information Technology
  • Machine Learning
  • Artificial Intelligence (Ai)
  • Life Science
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does OS Fund frequently co-invest with?

Vast Ventures
North America, New York, United States, New York
Co-Investments: 4
Draper Associates
North America, California, United States, San Mateo
Co-Investments: 5
Y Combinator
North America, California, United States, Mountain View
Co-Investments: 8
AME Cloud Ventures
North America, California, United States, Palo Alto
Co-Investments: 6
Wilson Sonsini Goodrich & Rosati
North America, California, United States, Palo Alto
Co-Investments: 4
Rising Tide
North America, California, United States, San Francisco
Co-Investments: 3
DCVC
North America, California, United States, San Francisco
Co-Investments: 8
Founders Fund
North America, California, United States, San Francisco
Co-Investments: 6
StartX (Stanford-StartX Fund)
North America, California, United States, Palo Alto
Co-Investments: 3
Khosla Ventures
North America, California, United States, Menlo Park
Co-Investments: 4

Which angels does OS Fund often collaborate with?

DM
North America, California, United States, San Francisco
Shared Deals: 1
BV
North America, California, United States, Los Angeles
Shared Deals: 1
Daniel Curran
North America, California, United States, Santa Monica
Shared Deals: 2
PP
North America, California, United States, San Francisco
Shared Deals: 1
LP
North America, California, United States, San Francisco
Shared Deals: 1
AL
North America, California, United States
Shared Deals: 1
DT
North America, Colorado, United States, Denver
Shared Deals: 1
KV
North America, California, United States, San Francisco
Shared Deals: 1
FN
North America, California, United States, Menlo Park
Shared Deals: 2
Chris Sang
Oceania, New South Wales, Australia, Sydney
Shared Deals: 1

What are some of recent deals done by OS Fund?

Arzeda

Seattle, Washington, United States

We harness the power of Intelligent Protein Design Technology™ to create enzyme products solving industry's toughest challenges

BiotechnologyInformation ServicesInformation TechnologyManufacturing
Series BMar 29, 2022
Amount Raised: $33,000,000
Kenota Health

Kitchener, Ontario, Canada

Kenota Health develops next-generation diagnostic tools intended to be used for allergy testing in humans.

BiotechnologyHealth CareHealth DiagnosticsMedical
Series ADec 7, 2020
Amount Raised: $9,000,000
A-Alpha Bio

Seattle, Washington, United States

A-Alpha Bio uses synthetic biology and machine learning to measure, discover, predict, and engineer protein-protein interactions.

BiotechnologyHealth CareLife ScienceTherapeutics
SeedSep 24, 2019
Amount Raised: $2,800,000
GRO Biosciences

Boston, Massachusetts, United States

GRO Biosciences is a biotechnology company that develops a protein therapeutics technology to improve treatments across multiple diseases.

BiotechnologyHealth DiagnosticsMedicalPharmaceuticalTherapeutics
SeedMar 13, 2019
Amount Raised: $3,500,000
Verge Genomics

San Francisco, California, United States

Verge Genomics uses machine learning and human genomics to accelerate drug discovery.

BiotechnologyGeneticsHealth CareMachine LearningNeuroscience
Series AJul 17, 2018
Amount Raised: $32,000,000
Lygos

Berkeley, California, United States

Lygos provides biotechnology solutions for today’s renewable chemical challenges.

Advanced MaterialsBiotechnologyClean Energy
Series BJul 17, 2018
Amount Raised: $15,500,000
Catalog

Boston, Massachusetts, United States

Catalog is a developer of a data conversion and storage platform used to offer the next generation of digital data archives.

AnalyticsBiotechnologyData StorageInformation ServicesInformation TechnologySoftware
SeedJun 26, 2018
Amount Raised: $4,000,000
NuMat Technologies

Skokie, Illinois, United States

NuMat Technologies builts an Operating System for the commercialization of programmable chemistries.

HardwareNanotechnologyRenewable EnergySemiconductor
Series BApr 26, 2018
Amount Raised: $12,400,000
Aria Pharmaceuticals

Palo Alto, California, United States

Aria Pharmaceuticals is a artificial intelligence-driven biopharmaceutical company.

Artificial Intelligence (AI)Big DataBiotechnologyHealth CarePharmaceutical
Series AMar 19, 2018
Amount Raised: $10,000,000
GRO Biosciences

Boston, Massachusetts, United States

GRO Biosciences is a biotechnology company that develops a protein therapeutics technology to improve treatments across multiple diseases.

BiotechnologyHealth DiagnosticsMedicalPharmaceuticalTherapeutics
SeedFeb 8, 2018
Amount Raised: $2,400,000